Back

Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Michaela Meyer

Bayer AG, Wuppertal (Germany)

42 More presentations in this session

Presentation thumbnail
Endomyocardial injections of autologous mesenchymal stem cell for treatment the patients with non-ischemic cardiomyopathy
Professor A. Kurlianskaya (Minsk, BY)
Abstract
Presentation thumbnail
Altered number of apoptotic-modified endothelial cells originated micro vesicles predict phenotypes of heart failure
Professor A. Berezin (Salzburg, AT)
Abstract Slides
Presentation thumbnail
The plastics of atrioventricular valve in patients with chronic heart failure and severe left ventricular dysfunction
Doctor O. Shatova (Minsk, BY)
Abstract
Presentation thumbnail
Slow and steady wins the race- the managment of tachycardia induced cardiomyopathy
Ms C. Farrell (Letterkenny, IE)
Abstract Slides
Presentation thumbnail
Higher levels of ferritin as a predictor of improvement of left ventricular ejection fraction in recent-onset idiopathic dilated cardiomyopathy
Doctor A. Giraldez Valpuesta (Jerez de la Frontera, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources